Results 31 to 40 of about 97,768,553 (153)

Selective proliferation of intestinal Barnesiella under fucosyllactose supplementation in mice [PDF]

open access: yes, 2014
The oligosaccharides 2-fucosyllactose and 3-fucosyllactose are major constituents of human breast milk but are not found in mouse milk. Milk oligosaccharides have a prebiotic action, thus affecting the colonisation of the infant intestine by microbiota ...
Hennet, Thierry   +6 more
core   +1 more source

Screening of Bifidobacteria with Probiotic Potential from Healthy Infant Feces by Using 2′-Fucosyllactose

open access: yesFoods, 2023
Using 2′-fucosyllactose (2′-FL) as the sole carbon source can be an efficient way to screen bifidobacteria with superior probiotic capabilities since 2′-FL is a key element in promoting the growth of intestinal bifidobacteria in newborns.
Gongsheng Zhang   +8 more
doaj   +1 more source

Plasmid Display for Stabilization of Enzymes Inside the Cell to Improve Whole-Cell Biotransformation Efficiency

open access: yesFrontiers in Bioengineering and Biotechnology, 2020
Recombinant whole-cell biocatalysts are widely used for biotransformation of valuable products. However, some key enzymes involved in biotransformation processes are unstable and cannot be easily expressed in the functional form.
Yunjeong Park   +15 more
doaj   +1 more source

Novel α-L-Fucosidases from a Soil Metagenome for Production of Fucosylated Human Milk Oligosaccharides. [PDF]

open access: yesPLoS ONE, 2016
This paper describes the discovery of novel α-L-fucosidases and evaluation of their potential to catalyse the transglycosylation reaction leading to production of fucosylated human milk oligosaccharides.
Mateusz Lezyk   +5 more
doaj   +1 more source

The human milk oligosaccharide 2'-fucosyllactose alleviates liver steatosis, ER stress, and insulin resistance by reducing hepatic diacylglycerols and improving gut permeability in obese Ldlr-/-Leiden mice [PDF]

open access: yes, 2022
Non-alcoholic fatty liver disease (NAFLD) is a complex multifactorial disorder that is associated with gut dysbiosis, enhanced gut permeability, adiposity and insulin resistance.
Attema, J.   +11 more
core   +1 more source

Correction: Precision synbiotic intervention with 2'-fucosyllactose and infant-derived Bifidobacterium modulates gut-immune axis and reduces disease risk in toddlers: a randomized controlled trial [PDF]

open access: yesFrontiers in Nutrition
Ke Chen   +17 more
doaj   +2 more sources

Evolutionary adaptation in fucosyllactose uptake systems supports bifidobacteria-infant symbiosis [PDF]

open access: yes, 2019
ビフィズス菌におけるヒトへの適応進化を発見 --母乳オリゴ糖トランスポーターの獲得形質がビフィズスフローラ形成を促す--. 京都大学プレスリリース. 2019-09-05.The human gut microbiota established during infancy has persistent effects on health.
Lo Leggio, Leila   +19 more
core   +1 more source

study [PDF]

open access: yes, 2023
We explored the potential for the prebiotic oligofructose and prebiotic candidate 2'fucosyllactose, alone and in combination (50:50 blend) to induce physiologically relevant increases in neurotransmitter (γ-aminobutyric acid, serotonin, tryptophan, and ...
Robert Adrian Rastall   +5 more
core   +1 more source

Determination of 2′-Fucosyllactose and Lacto-N-neotetraose in Infant Formula

open access: yesMolecules, 2018
Human milk oligosaccharides (HMO) are the third most abundant solid component of human milk. It is likely that they are responsible for at least some of the benefits experienced by breast-fed infants.
Sean Austin   +4 more
doaj   +1 more source

Influence of 2′-Fucosyllactose on the Microbiota Composition and Metabolic Activity of Fecal Cultures from Breastfed and Formula-Fed Infants at Two Months of Age

open access: yesMicroorganisms, 2021
Although breast milk is considered the gold standard of nutrition for infant feeding, some circumstances may make breastfeeding difficult. Several commercial milk preparations include synthetic human milk oligosaccharides (HMOs) in their composition ...
Alicja M. Nogacka   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy